172 related articles for article (PubMed ID: 10048975)
1. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y
Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975
[TBL] [Abstract][Full Text] [Related]
2. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V; Nakano S
Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
[TBL] [Abstract][Full Text] [Related]
3. Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.
Boudny V; Nakano S
Br J Cancer; 2002 Feb; 86(3):463-9. PubMed ID: 11875716
[TBL] [Abstract][Full Text] [Related]
4. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
[TBL] [Abstract][Full Text] [Related]
5. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
6. [Cell signaling and CDDP resistance].
Masumoto N; Nakano S
Gan To Kagaku Ryoho; 1997 Feb; 24(4):424-30. PubMed ID: 9063479
[TBL] [Abstract][Full Text] [Related]
7. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
Machida K; Matsuda S; Yamaki K; Senga T; Thant AA; Kurata H; Miyazaki K; Hayashi K; Okuda T; Kitamura T; Hayakawa T; Hamaguchi M
Oncogene; 2000 Mar; 19(13):1710-8. PubMed ID: 10763828
[TBL] [Abstract][Full Text] [Related]
8. Src kinase and PI 3-kinase as a transduction pathway in ceramide-induced contraction of colonic smooth muscle.
Ibitayo AI; Tsunoda Y; Nozu F; Owyang C; Bitar KN
Am J Physiol; 1998 Oct; 275(4):G705-11. PubMed ID: 9756500
[TBL] [Abstract][Full Text] [Related]
9. UCS15A, a non-kinase inhibitor of Src signal transduction.
Sharma SV; Oneyama C; Yamashita Y; Nakano H; Sugawara K; Hamada M; Kosaka N; Tamaoki T
Oncogene; 2001 Apr; 20(17):2068-79. PubMed ID: 11360191
[TBL] [Abstract][Full Text] [Related]
10. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein.
Touhara K; Hawes BE; van Biesen T; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9284-7. PubMed ID: 7568118
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha and -gamma inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing Src tyrosine kinase activity.
Fujishima H; Nakano S; Tatsumoto T; Masumoto N; Niho Y
Int J Cancer; 1998 May; 76(3):423-9. PubMed ID: 9579582
[TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of csk inhibits acid-induced activation of NHE-3.
Yamaji Y; Amemiya M; Cano A; Preisig PA; Miller RT; Moe OW; Alpern RJ
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6274-8. PubMed ID: 7541536
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.
Esparza J; Vilardell C; Calvo J; Juan M; Vives J; Urbano-Márquez A; Yagüe J; Cid MC
Blood; 1999 Oct; 94(8):2754-66. PubMed ID: 10515879
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction via both human low-affinity IgG Fc receptors, Fc gamma RIIa and Fc gamma RIIIb, depends on the activity of different families of intracellular kinases.
Ebel C; Schmidt RE; Hundt M
Immunobiology; 2001 May; 203(4):616-28. PubMed ID: 11402496
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line.
Murakami Y; Nakano S; Niho Y; Hamasaki N; Izuhara K
J Cell Physiol; 1998 May; 175(2):220-8. PubMed ID: 9525481
[TBL] [Abstract][Full Text] [Related]
17. Suppression of anoikis by v-Src but not by activated c-H-ras in human gallbladder epithelial cells.
Hisano C; Tanaka R; Fujishima H; Ariyama H; Tsuchiya T; Tatsumoto T; Mitsugi K; Nakamura M; Nakano S
Cell Biol Int; 2003; 27(5):415-21. PubMed ID: 12758089
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces.
Fukazawa H; Nakano S; Mizuno S; Uehara Y
Int J Cancer; 1996 Sep; 67(6):876-82. PubMed ID: 8824562
[TBL] [Abstract][Full Text] [Related]
19. Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the ras-GTP complex.
Kwon HJ; Yoshida M; Muroya K; Hattori S; Nishida E; Fukui Y; Beppu T; Horinouchi S
J Biochem; 1995 Jul; 118(1):221-8. PubMed ID: 8537316
[TBL] [Abstract][Full Text] [Related]
20. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]